Home
Products
Learn
About
Pricing
Log In
OILR

This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.

Asset Logo

Optiscan Imaging Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

N/A
Annual Growth

5 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

1
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Optiscan Imaging Limited - Rights - Applications Close 29-Jun-2023

๐Ÿ“ˆ Performance

Price History

N/A

1M

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in OILR

0

๐Ÿ“Š Total Capital Earnings

N/A

๐Ÿ”ƒ Average investment frequency

N/A

๐Ÿ’ต Average investment amount

N/A

โฐ Last time a customer invested in OILR

N/A
OILR investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

๐Ÿ™‹ Legal gender of investors

Female

Male

Pearlers who invest in OILR also invest in...

Betashares Australian Sustainability Leaders ETF

FAIR

FAIR.AX was created on 2017-11-27 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes Australian companies that have passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

๐Ÿ™Œ Performance (5Yr p.a)

6.04%

๐Ÿ“Š Share price

$20.18 AUD

โ›ณ๏ธ DIVERSIFIED

Find Out More

VSO.AX was created on 2011-05-23 by Vanguard. The fund's investment portfolio concentrates primarily on small cap equity. Vanguard MSCI Australian Small Companies Index ETF seeks to track the return of the MSCI Australian Shares Small Cap Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

8.12%

๐Ÿ“Š Share price

$65.19 AUD

๐Ÿงฑ MATERIALS

โ›ณ๏ธ DIVERSIFIED

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

๐Ÿ™Œ Performance (5Yr p.a)

17.41%

๐Ÿ“Š Share price

$411.25 AUD

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

โ›ณ๏ธ DIVERSIFIED

IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

๐Ÿ™Œ Performance (5Yr p.a)

17.88%

๐Ÿ“Š Share price

$55.80 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿ’ฐ HIGH DIVIDEND

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

๐Ÿ™Œ Performance (5Yr p.a)

9.10%

๐Ÿ“Š Share price

$14.52 AUD

๐Ÿค– TECHNOLOGY

โ›ณ๏ธ DIVERSIFIED

๐Ÿ’ธ FINANCIALS

๐Ÿ“ˆ HIGH PRICE GROWTH

๐ŸŒ GLOBAL

Want more shares? Try these...

The Original Juice Co. Ltd. produces fruit & vegetable juices and other products. The company is engaged in the manufacture of a range of functional juices, fibers, infused fruits and fruit waters for sale as branded products and/or ingredients; the provision of co-packing services to third parties, and the research and development of various food related technologies to develop new functional food products and ingredients. The company uses a combination of conventional juice processing equipment and custom-developed equipment and processes to manufacture a range of juices, fibers, infused fruits and fruit waters that are sold as branded products or ingredients to customers domestically and oversea. Its products include Black Label Orange, Black Label Apple, Black Label Grapefruit, and Veggie Goodness. Black Label Orange is a fruit juice with no added sugar and is bottled within 12 hours. Black Label Grapefruit is invigoratingly tart and semi-sweet, a natural tonic and detoxifier with a daily dose of vitamin C.

๐Ÿ™Œ Performance (5Yr p.a)

92.50%

๐Ÿ“Š Share price

$1.80 AUD

๐Ÿ” FOOD PRODUCTS

Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The company is headquartered in Mulgrave, Victoria. The Companyโ€™s technology enables real-time, non-destructive, three-dimensional (3D), in-vivo imaging at the single-cell level. The company provides real-time microscopic imaging tools to healthcare providers and researchers to enable the early detection and management of disease. Its InVivage device is developed for clinical use in oral cancer and other cancer applications. Its Fluorescence In Vivo Endomicroscopy (FIVE2) also known as ViewnVivo system, is a hand-held, confocal microscope designed for pre-clinical use. This device is targeted for use by universities and medical research institutions to explore potential applications of the technology through laboratory testing of tissue samples.